152 related articles for article (PubMed ID: 16677841)
1. [Update of 'standards, options and recommendations' for FDG-PET in breast and gynaecological cancers].
Talbot JN; Grahek D
Gynecol Obstet Fertil; 2006 May; 34(5):434-6. PubMed ID: 16677841
[No Abstract] [Full Text] [Related]
2. [2003 update of recommendations for clinical practice: standards, options and recommendations for the use of FDG-PET in the management of gynaecological and breast cancers].
FNCLCC
Gynecol Obstet Fertil; 2004 Apr; 32(4):352-71. PubMed ID: 15123109
[No Abstract] [Full Text] [Related]
3. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in gynecological neoplasms].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S47-55. PubMed ID: 12739336
[No Abstract] [Full Text] [Related]
4. [Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynaecological and breast cancers].
Grahek D; Barranger E; Daraï E; Uzan S; Talbot JN
Gynecol Obstet Fertil; 2005 Jun; 33(6):371-81. PubMed ID: 15927502
[TBL] [Abstract][Full Text] [Related]
5. [2005 monitoring report: use of positron emission tomography with fluorodeoxyglucose in the management of patients with breast cancer, ovarian cancer, and uterine cancer].
Bourguet P; Hitzel A; Houvenaeghel G; Vinatier D; Bosquet L
Gynecol Obstet Fertil; 2006 May; 34(5):437-59. PubMed ID: 16821280
[TBL] [Abstract][Full Text] [Related]
6. [Utilization of PET scan in breast and gynaecologic cancers].
Huglo D; Vinatier D
Gynecol Obstet Fertil; 2004 Apr; 32(4):330-9. PubMed ID: 15123104
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis bulletin of 2005 surveillance. Clinical practice recommendations: the use of PET-FDG in cancers of the breast, ovary and uterus].
Bourguet P; Hitzel A; Houvenaeghel G; Vinatier D; Bosquet L; Bonichon F; Corone C; Giard-Lefèvre S; Morett JL; Touboul E; ; ; ; ; ; ; ;
Bull Cancer; 2006 Apr; 93(4):385-90. PubMed ID: 16714228
[No Abstract] [Full Text] [Related]
8. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
Torizuka T; Kanno T; Futatsubashi M; Okada H; Yoshikawa E; Nakamura F; Takekuma M; Maeda M; Ouchi Y
J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET in gynaecological cancers: recent observations.
Lucignani G
Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2133-9. PubMed ID: 18779962
[No Abstract] [Full Text] [Related]
10. Evaluation of breast and gynecologic cancers by positron emission tomography.
Dehdashti F; Siegel BA
Semin Roentgenol; 2002 Apr; 37(2):151-68. PubMed ID: 12134368
[No Abstract] [Full Text] [Related]
11. FDG-PET Assessment of Other Gynecologic Cancers.
Faria S; Devine C; Viswanathan C; Javadi S; Korivi BR; Bhosale PR
PET Clin; 2018 Apr; 13(2):203-223. PubMed ID: 29482750
[TBL] [Abstract][Full Text] [Related]
12. [Standards, Options and Recommendations 2002 for the use of Positron Emission Tomography with [18F]-FDG (PET-FDG in cancerology (integral connection].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S5-17. PubMed ID: 12739332
[TBL] [Abstract][Full Text] [Related]
13. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in unknown primary neoplasms].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S103-4. PubMed ID: 12739342
[No Abstract] [Full Text] [Related]
14. [Complex angiographic diagnosis of recurrences of gynaecological tumours. Technique, indications, results].
Fritz H; Köhler K; Platzbecker H
Fortschr Geb Rontgenstr Nuklearmed; 1972 Aug; 117(2):117-29. PubMed ID: 4341836
[No Abstract] [Full Text] [Related]
15. [Lymphography. Possibilities and limits of metastasis diagnosis in female genital carcinoma].
Frischbier HJ
Geburtshilfe Frauenheilkd; 1966 Sep; 26(9):1255-71. PubMed ID: 5996489
[No Abstract] [Full Text] [Related]
16. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in sarcomas].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S96-102. PubMed ID: 12739341
[No Abstract] [Full Text] [Related]
17. Critical appraisal of lymphangiography in cancer of the female genital tract.
Lecart C; Lenfant P
Lymphology; 1971 Sep; 4(3):100-8. PubMed ID: 5098883
[No Abstract] [Full Text] [Related]
18. A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration.
Husain A; Akhurst T; Larson S; Alektiar K; Barakat RR; Chi DS
Gynecol Oncol; 2007 Jul; 106(1):177-80. PubMed ID: 17477959
[TBL] [Abstract][Full Text] [Related]
19. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in digestive system neoplasms].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S56-66. PubMed ID: 12739337
[No Abstract] [Full Text] [Related]
20. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S67-79. PubMed ID: 12739338
[No Abstract] [Full Text] [Related]
[Next] [New Search]
